|
Genotype
|
Sample no. (%)
|
BDI scorea
|
Codominant p value
|
Dominant p value
|
Recessive p value
|
Log-additive p value
|
|---|
|
Total (n = 186)
|
|
TT
|
41 (22.0)
|
12.56 ± 1.62
|
0.009**
|
0.144
|
0.002**
|
0.006**
|
|
CT
|
89 (47.8)
|
8.83 ± 0.97
| | | | |
|
CC
|
56 (30.1)
|
7.06 ± 1.72
| | | | |
|
Male (n = 60)
|
|
TT
|
15 (25.0)
|
8.10 ± 1.22
|
0.093
|
0.050
|
0.107
|
0.029*
|
|
CT
|
26 (43.3)
|
8.50 ± 2.09
| | | | |
|
CC
|
19 (31.7)
|
6.36 ± 3.15
| | | | |
|
Female (n = 126)
|
|
TT
|
26 (20.6)
|
15.18 ± 2.25
|
0.007**
|
0.381
|
0.002**
|
0.015*
|
|
CT
|
63 (50.0)
|
8.95 ± 1.10
| | | | |
|
CC
|
37 (29.4)
|
7.43 ± 2.09
| | | | |
- aMean ± standard error (s.e.). The p value was adjusted for GCS, GOSE, injury mechanism, antidepressant medication use and hypnotic medication use. *0.01 ≤ p < 0.05 is labeled in bold. **p < 0.01 is labeled in bold
